Review
Growth factors in angiogenesis: current interest and therapeutic potential

https://doi.org/10.1016/S1357-4310(96)10048-4Get rights and content

Angiogenesis, the process of new blood vessel development, is an essential component of the body's physiology and contributes to the pathogenesis of a variety of diseases such as benign and malignant neoplasia and rheumatoid arthritis. Failure of this physiological response is also important in abnormalities of wound healing in diseases such as duodenal ulceration and diabetes. Angiogenesis is controlled by a variety of factors that initiate, control and terminate this complex, multi-stage process. This review covers those factors that are exciting much interest currently and have potential for incorporation into clinical medicine.

References (59)

  • MousaS.A.

    Angiogenesis promoters and inhibitors: potential therapeutic implications

    Mol. Med. Today

    (1996)
  • FolkmanJ.

    How is blood vessel growth regulated in normal and neoplastic tissue? (G.H.A. Clowes memorial Award lecture)

    Cancer Res.

    (1986)
  • Colville-NashP.R. et al.

    Angiogenesis and rheumatoid arthritis: pathogenic and therapeutic implications

    Ann. Rheum. Dis.

    (1992)
  • AbbotS.E. et al.

    Isolation and culture of synovial microvascular endothelial cells. Characterization and assessment of adhesion molecule expression

    Arthritis Rheum.

    (1992)
  • KralingB.M. et al.

    Isolation and characterization of microvascular endothelial cells from the adult human dermis and from skin biopsies of patients with systemic sclerosis

    Lab. Invest.

    (1994)
  • Frater-SchroderM.

    Tumour necrosis factor α, a potent inhibitor of endothelial cell growth in vitro, is angiogenic in vivo

  • Colville-NashP.R.

    The pharmacological modulation of angiogenesis in chronic granulomatous inflammation

    J. Pharmacol. Exp. Ther.

    (1995)
  • AndradeS.P. et al.

    Quantitative in vivo studies on angiogenesis in a rat sponge model

    Br. J. Exp. Pathol.

    (1987)
  • KlagsbrunM. et al.

    Regulators of angiogenesis

    Annu. Rev. Physiol.

    (1991)
  • Colville-NashP.R. et al.

    The current state of angiostatic therapy, with special reference to rheumatoid arthritis

    Curr. Opin. Invest. Drugs

    (1993)
  • DvorakH.F. et al.

    Vascular permeability factor/vascular endothelial growth factor, microvascular permeability, and angiogenesis

    Am. J. Pathol.

    (1995)
  • VlodavskyI.

    Extracellular matrix-resident growth factors and enzymes: possible involvement in tumour metastasis and angiogenesis

    Cancer Metastasis Rev.

    (1990)
  • SengerD.R.

    Commentary: molecular framework for angiogenesis. A complex web of interactions between extravasated plasma proteins and endothelial cell proteins induced by angiogenic cytokines

    Am. J. Pathol.

    (1996)
  • ShweikiD.

    Patterns of expression of vascular endothelial growth factor (VEGF) and VEGF receptors suggest a role in hormonally regulated angiogenesis

    J. Clin. Invest.

    (1993)
  • ShalabyF.

    Failure in blood island formation and vasculogenesis in Flk-1-deficient mice

    Nature

    (1995)
  • AsaharaT.

    Local delivery of vascular endothelial growth factor accelerates re-endothelialization and attenuates intimal hyperplasia in balloon-injured rat carotid artery

    Circulation

    (1995)
  • KuzuyaM.

    Induction of angiogenesis by smooth muscle cell-derived factor: possible role in neovascularization in atherosclerotic plaque

    J. Cell Physiol.

    (1995)
  • KimK.J.

    Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo

    Nature

    (1993)
  • AppletonI.

    The role of vascular endothelial growth factor in a murine chronic granulomatous tissue airpouch model of angiogenesis

    J. Pathol.

    (1996)
  • Cited by (0)

    View full text